Table 2 FDA custom MACE end point
The following MedDRA preferred terms (version 15.0) are included in the FDA custom MACE end point: | |
|---|---|
Myocardial infarction terms | Stroke terms |
Myocardial Infarction terms | Basilar artery thrombosis |
Acute myocardial infarction | Brain stem infarction |
Coronary artery thrombosis | Brain stem stroke |
Myocardial infarction | Brain stem thrombosis |
Papillary muscle infarction | Carotid arterial embolus |
Postprocedural myocardial infarction | Carotid artery thrombosis |
Silent myocardial infarction | Cerebellar infarction |
| Â | Cerebral artery embolism |
| Â | Cerebral artery thrombosis |
| Â | Embolic stroke |
| Â | Haemorrhagic cerebral infarction |
| Â | Haemorrhagic stroke |
| Â | Haemorrhagic transformation stroke |
| Â | Ischaemic cerebral infarction |
| Â | Ischaemic stroke |
| Â | Lacunar infarction |
| Â | Lateral medullary syndrome |
| Â | Moyamoya disease |
| Â | Postprocedural stroke |
| Â | Stroke in evolution |
| Â | Thalamic infarction |
| Â | Thrombotic cerebral infarction |
| Â | Thrombotic stroke |
| Â | Wallenberg syndrome |